At the industry's top events, pharma professionals can dive into these issues and more through educational sessions, networking events and keynote presentations from industry leaders. Here's a look at ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026" has been added to ResearchAndMarkets.com's offering. The Manufacturing and ...

While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world's largest ...

September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals.

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2021-2026" has been added to ...

December 2025 marked an exceptionally active period for life sciences regulation in the European Union (EU). Within the space of a few days, EU institutions have reached political agreement on the ...

Fully revised and updated, the report analyzes asset purchase agreements announced since 2019, giving business development, licensing, and corporate strategy professionals a detailed view of how ...

Currently, SXTC is trading at $6.60, up 456.59%. VERAXA Biotech develops next-generation antibody-based cancer therapies, including BiTAC T cell engagers and bispecific antibody-drug conjugates.The ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...